Rian Torbjørn, Sand Kari, Skogvoll Eirik, Klepstad Pål, Wik Tina S
Department of Anaesthesiology and Intensive Care Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
JMIR Form Res. 2022 Apr 28;6(4):e34543. doi: 10.2196/34543.
We report the use of an electronic tool, Eir (Eir Solutions AS, Norway), for symptom registration at home after knee arthroplasty. This electronic tool was used in a randomized controlled trial (RCT) comparing 3 different analgesic regimens with respect to postoperative pain and side effects.
The aim of this substudy was to investigate this electronic tool for symptom registrations at home with respect to usability (ie, how easy it was to use) and feasibility (ie, how well the tool served its purpose).
To assess the tool's usability, all participants were invited to fill out the 10-item System Usability Scale (SUS) after using the tool for 8 days. To assess feasibility, data regarding the participants' ability to use the tool with or without assistance or reminders were collected qualitatively on a daily basis during the study period.
A total of 134 patients completed the RCT. Data concerning feasibility of the web-based tool were collected from all 134 patients. The SUS was completed by 119 of the 134 patients; 70.2% (94/134) of the patients managed to use the tool at home without any technical support. All technical challenges were related to the login procedure or internet access. The mean SUS score was 89.6 (median 92.5; range 22.5-100).
This study showed high feasibility and high usability of the Eir web tool. The received reports gave the necessary information needed for both research data and clinical follow-up.
ClinicalTrials.gov NCT02604446; https://www.clinicaltrials.gov/ct2/show/NCT02604446.
我们报告了一种电子工具Eir(挪威Eir Solutions AS公司)在膝关节置换术后家庭症状登记中的应用。该电子工具用于一项随机对照试验(RCT),比较3种不同镇痛方案在术后疼痛和副作用方面的情况。
本亚研究的目的是调查这种用于家庭症状登记的电子工具在可用性(即使用的难易程度)和可行性(即工具实现其目的的程度)方面的情况。
为评估该工具的可用性,所有参与者在使用该工具8天后被邀请填写10项系统可用性量表(SUS)。为评估可行性,在研究期间每天定性收集有关参与者在有无协助或提醒情况下使用该工具能力的数据。
共有134例患者完成了RCT。从所有134例患者中收集了有关该基于网络工具可行性的数据。134例患者中有119例完成了SUS量表;70.2%(94/134)的患者能够在家中无需任何技术支持使用该工具。所有技术难题均与登录程序或互联网接入有关。SUS量表的平均得分为89.6(中位数92.5;范围22.5 - 100)。
本研究表明Eir网络工具具有高可行性和高可用性。所收到的报告提供了研究数据和临床随访所需的必要信息。
ClinicalTrials.gov NCT02604446;https://www.clinicaltrials.gov/ct2/show/NCT02604446 。